ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 26 Aug 2024
Last Applicant/ Owned by
3115 Merryfield Row, Suite 200
San Diego
CA
92121
Serial Number
90324817 filed on 17th Nov 2020
Registration Number
N/A
Correspondent Address
Rosaleen H. Chou
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
RESILIENCEX
Research and development in the field of manufacturing processes for pharmaceuticals, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; software as a service (SAAS) services featuring non-downloadable software for use in the manufacture of advanced therapy and cell therapy medications; providing scientific and technical information in the field of scientific Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of manufacturing processes for pharmaceuticals, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; software as a service (SAAS) services featuring non-downloadable software for use in the manufacture of advanced therapy and cell therapy medications; providing scientific and technical information in the field of scientific research about pharmaceuticals; providing scientific information in the field of biomanufacturing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
downloadable computer software for use in the manufacture of advanced therapy and cell therapy medications
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacturing of pharmaceuticals and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90324817
Mark Type
No Service Mark
Attorney Docket Number
No NATIR.005T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Aug 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 26th Aug 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 27th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 25th Jan 2024 | SOU EXTENSION 1 GRANTED |
| 25th Jan 2024 | SOU EXTENSION 1 FILED |
| 25th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
| 14th Nov 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 14th Nov 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 14th Nov 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 25th Jul 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |